Ranchoux et al. found that serum soluble CD14 was obviously higher in patients with idiopathic PAH and hereditary PAH carrying the BMPR2 mutation compared to control groups (Ranchoux et al., 2017). Here, CD14 is linked to pulmonary arterial hypertension.